268 related articles for article (PubMed ID: 21643739)
1. Serum interleukin-33 levels in patients with gastric cancer.
Sun P; Ben Q; Tu S; Dong W; Qi X; Wu Y
Dig Dis Sci; 2011 Dec; 56(12):3596-601. PubMed ID: 21643739
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
4. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
Xue T; Yang J; Song P; Zhou G
J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 and -10 levels in patients with gastric cancer.
Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S
Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of interleukin-37 correlate with poor prognosis in gastric cancer.
Zhang Y; Tang M; Wang XG; Gu JH; Zhou LN; Jin J; Li P; Wang LQ; Chen MB
Rev Esp Enferm Dig; 2019 Dec; 111(12):941-945. PubMed ID: 31718212
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
8. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
[TBL] [Abstract][Full Text] [Related]
9. Serum level of interleukin-35 as a potential prognostic factor for gastric cancer.
Gu JH; Wang XG; Wang LQ; Zhou LN; Tang M; Li P; Wu XY; Chen MB; Zhang Y
Asia Pac J Clin Oncol; 2021 Feb; 17(1):52-59. PubMed ID: 33044052
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma.
Kawabata T; Ichikura T; Majima T; Seki S; Chochi K; Takayama E; Hiraide H; Mochizuki H
Cancer; 2001 Oct; 92(8):2050-5. PubMed ID: 11596019
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer.
Forones NM; Mandowsky SV; Lourenço LG
Hepatogastroenterology; 2001; 48(40):1199-201. PubMed ID: 11490833
[TBL] [Abstract][Full Text] [Related]
14. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
15. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
16. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
18. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
Bilici A; Ustaalioglu BB; Ercan S; Seker M; Yilmaz BE; Orcun A; Gumus M
Tumour Biol; 2012 Dec; 33(6):2201-8. PubMed ID: 22890829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]